Status:
COMPLETED
Heart Rate Variability and Cardiorespiratory Complications During Ophthalmic Arterial Chemotherapy for Retinoblastoma
Lead Sponsor:
Seoul National University Hospital
Conditions:
Parasympathetic Cardiovascular Function Disorder
Eligibility:
All Genders
Up to 20 years
Brief Summary
A patient undergoing ophthalmic arterial chemosurgery may experience a sudden, profound decrease in lung compliance when the microcatheter is in the ICA or ophthalmic artery. However, underlying patho...
Detailed Description
A patient undergoing ophthalmic arterial chemosurgery may experience a sudden, profound decrease in lung compliance when the microcatheter is in the ICA or ophthalmic artery. However, underlying patho...
Eligibility Criteria
Inclusion
- Patients undergoing ophthalmic arterial chemotherapy
Exclusion
- None
Key Trial Info
Start Date :
April 9 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 9 2019
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT03450590
Start Date
April 9 2018
End Date
September 9 2019
Last Update
October 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 03080